A novel synthetic peptide derivative from lactoferrin exhibiting antimicrobial activity.
A tetrapeptide derivative Boc-L-Lys(Boc)-L-Arg-L-Asp-L-Ser(Bu(t))-OBu(t) (PEP 1261; Boc is butoxycarbonyl, Bu(t) is t-butyl and OBu(t) is t-butyl ester), synthesized by a solution-phase strategy, exhibited antimicrobial activity against a broad spectrum of micro-organisms at an optimal concentration of 500 mug/ml. Whereas the tetrapeptide salt (L-Lys-L-Arg-L-Asp-L-Ser.HCl) was found to be fairly effective against bacterial cultures, it was not effective against fungal cultures. Comparative growth studies showed that PEP 1261 was equally as potent as the conventional antibiotics kanamycin, streptomycin and actidione for the Gram-negative bacteria Escherichia coli, Pseudomonas alcaligenes and the non-filamentous fungus Saccharomyces cerevisiae (baker's yeast), whereas 62 and 88.9% inhibition were observed for Gram-positive organisms such as Staphylococcus aureus and Bacillus thuringiensis respectively. PEP 1261 might exert its antimicrobial activity by permeabilizing the bacterial membrane, and this was confirmed by an increase in beta-galactosidase activity.
Ramesh
Chintala Venkataramana
CV
Department of Biotechnology, Central Leather Research Institute, Adyar, Madras 600020, India.
Kamini
Numbi Ramudu
NR
Puvanakrishnan
Rengarajulu
R
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology; D023181:Antimicrobial Cationic Peptides / Q000138:chemical synthesis* / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D002463:Cell Membrane Permeability / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005658:Fungi / Q000187:drug effects*; D007781:Lactoferrin / Q000737:chemistry*
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D023181:Antimicrobial Cationic Peptides; D007781:Lactoferrin